73 related articles for article (PubMed ID: 11521426)
1. [Effectiveness of bio-regulators in the treatment of diabetic retinopathy].
Trofimova SV; Khavinson VKh
Vestn Oftalmol; 2001; 117(3):11-4. PubMed ID: 11521426
[TBL] [Abstract][Full Text] [Related]
2. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
3. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
4. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
[TBL] [Abstract][Full Text] [Related]
5. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
Tunc M; Onder HI; Kaya M
Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
[TBL] [Abstract][Full Text] [Related]
6. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
7. Overnight thickness variation in diabetic macular edema.
Larsen M; Wang M; Sander B
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2313-6. PubMed ID: 15980216
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Gibran SK; Khan K; Jungkim S; Cleary PE
Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of eiconol in patients with diabetic retinopathy].
Sorokin EL; Smoliakova GP; Bachaldin IL
Vestn Oftalmol; 1997; 113(4):37-9. PubMed ID: 9381643
[TBL] [Abstract][Full Text] [Related]
10. Interobserver agreement in the interpretation of single-field digital fundus images for diabetic retinopathy screening.
Ruamviboonsuk P; Teerasuwanajak K; Tiensuwan M; Yuttitham K;
Ophthalmology; 2006 May; 113(5):826-32. PubMed ID: 16650679
[TBL] [Abstract][Full Text] [Related]
11. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.
Tranos PG; Topouzis F; Stangos NT; Dimitrakos S; Economidis P; Harris M; Coleman AL
Curr Eye Res; 2004 Jul; 29(1):41-9. PubMed ID: 15370366
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
14. Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema.
Kolacny D; Parys-Vanginderdeuren R; Van Lommel A; Stalmans P
Bull Soc Belge Ophtalmol; 2005; (296):15-23. PubMed ID: 16050416
[TBL] [Abstract][Full Text] [Related]
15. The use of intravitreal etanercept in diabetic macular oedema.
Tsilimbaris MK; Panagiotoglou TD; Charisis SK; Anastasakis A; Krikonis TS; Christodoulakis E
Semin Ophthalmol; 2007; 22(2):75-9. PubMed ID: 17564925
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
[TBL] [Abstract][Full Text] [Related]
17. [Use of atromide-S in the treatment of diabetic retinopathy].
Kliachko VR; Tirkina TN; Aleksandrova LM; Mazovetskiĭ AG
Sov Med; 1973 Dec; 36(12):59-61. PubMed ID: 4779364
[No Abstract] [Full Text] [Related]
18. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
[TBL] [Abstract][Full Text] [Related]
19. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
